Video Experimental Relacionado

Updated: Jul 9, 2026

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Síndrome metabólico y masa ventricular izquierda ecocardiográfica en negros: el estudio de riesgo de aterosclerosis

Cecil M Burchfiel¹, Thomas N Skelton, Michael E Andrew

¹Jackson Heart Study, National Heart, Lung, and Blood Institute, Jackson, Mississippi, USA. cburchfiel@cdc.gov

|August 3, 2005

Resumen

El síndrome metabólico está relacionado con el aumento de la masa ventricular izquierda (LV) en adultos negros. Esta asociación es impulsada principalmente por el grosor de la pared LV, no el tamaño de la cámara, destacando los riesgos cardiovasculares.

Área de la Ciencia:

Salud Cardiovascular La salud cardiovascular.
Trastornos metabólicos Los trastornos metabólicos son trastornos metabólicos que se producen en el cuerpo.
La ecocardiografía es una ecocardiografía.

Sus antecedentes:

El síndrome metabólico está asociado con enfermedades cardiovasculares.
Existe una investigación limitada sobre el vínculo del síndrome metabólico con medidas subclínicas como la masa ventricular izquierda (LV).
Esta relación es crucial en las poblaciones negras donde el síndrome metabólico y la hipertrofia de LV son prevalentes.

Objetivo del estudio:

Para investigar la relación entre el síndrome metabólico y la masa ventricular izquierda (LV) ecocardiográfica.
Para examinar esta asociación específicamente dentro de una población negra, teniendo en cuenta la alta prevalencia de ambas condiciones.

Principales métodos:

La ecocardiografía evaluó las dimensiones de LV en 1572 adultos negros (de 49 a 75 años) del Estudio de Riesgo de Aterosclerosis en Comunidades (ARIC).
Los participantes fueron agrupados por el número de características del síndrome metabólico: hipertensión, dislipidemia e intolerancia a la glucosa.
Análisis estadísticos ajustados por factores de estilo de vida y adiposidad central.

Principales resultados:

Se observó un aumento significativo y gradual de la masa de LV indexada por la altura con un mayor número de características del síndrome metabólico.
El espesor de la pared posterior de LV y el tabique interventricular, pero no el tamaño de la cámara de LV, se asociaron significativamente con el agrupamiento del síndrome metabólico.
La hipertensión mostró una fuerte influencia, con dislipidemia y intolerancia a la glucosa contribuyendo, pero no se encontraron efectos sinérgicos significativos.

Conclusiones:

En hombres y mujeres negros, el agrupamiento del síndrome metabólico está fuertemente asociado con un aumento de la masa de LV y el grosor de la pared.
Estos hallazgos sugieren que factores subyacentes como la resistencia a la insulina pueden influir en el engrosamiento del miocardio, no en la dilatación de la cámara.
El estudio destaca un vínculo crítico entre la salud metabólica y los cambios estructurales cardíacos subclínicos en esta población.

Más Videos Relacionados

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery

Published on: February 20, 2017

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

Videos de Conceptos Relacionados

Imaging Studies for Cardiovascular System I:Echocardiography

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...